93 / 164
ESTRO SCHOOL
93
ROADMAP
Vincenzo Valentini
Regina Beets-Tan
FACULTY
COURSE DIRECTORS
• Regina Beets-Tan,
Radiologist, Netherlands Cancer Institute,
Amsterdam (NL)
• Vincenzo Valentini,
Radiation Oncologist, Università
Cattolica S. Cuore, Rome (IT)
TEACHERS
The teaching faculty is being updated, please visit www.estro-
education.org/coursesfor the latest information.
RADIATION ONCOLOGIST, OTHER SPECIALIST
IMAGING
• How can we adapt the treatment at the beginning
and along the therapies by imaging?
• Workshops rectal cancer.
PREREQUISITES
Before commencing this course participants should:
• Review main international guidelines on the course
topics
• Participate in tumour boards on the course topics at
their institution.
TEACHINGMETHODS
• 7 hours of lectures
• 2 hours of practical workshops
• 6 hours of case discussions.
The course consists of didactic lectures, case discussions
in small working groups and plenary debates.
METHODS OF ASSESSMENT
• MCQ
• Interactive workshops
• Evaluation form.
KEYWORDS
Imaging, multidisciplinary, combined modality treat-
ments, personalised oncology, upper abdomen, prostate
cancer, rectal cancer.
ACCREDITATION
Application for CME recognition will be submitted to
the European Accreditation Council for Continuing
Medical Education (EACCME), an institution of the
European Union of Medical Specialists (UEMS). EAC-
CME credits are recognised by the American Medical
Association towards the Physician’s Recognition Award
(PRA). Information on the status of the applications
can be obtained from the ESTRO office.
WHICH IMAGING COURSE TO CHOOSE?
ESTRO also organises a course on target volume deter-
mination (TVD): from imaging to margins (see page 62)
The TVD course is aimed at trainees in radiation oncology,
radiation physicists and RTT or at seniors as a refresher course
The TVD course provides the fundamental understanding
for the use of imaging for the TVD of tumours seen in
general and routine clinical radiation oncology practice.
The TVD course covers the following sites: CNS, H&N,
breast, lung and pelvic tumours.